Reina-Couto, M., Alves, D., Silva-Pereira, C., Pereira-Terra, P., Martins, S., Bessa, J., . . . Sousa, T. (2025). Endocan as a marker of endotheliitis in COVID-19 patients: Modulation by veno-venous extracorporeal membrane oxygenation, arterial hypertension and previous treatment with renin-angiotensin-aldosterone system inhibitors.
Citação norma ChicagoReina-Couto, M., et al. Endocan as a Marker of Endotheliitis in COVID-19 Patients: Modulation by Veno-venous Extracorporeal Membrane Oxygenation, Arterial Hypertension and Previous Treatment with Renin-angiotensin-aldosterone System Inhibitors. 2025.
Citação norma MLAReina-Couto, M., et al. Endocan as a Marker of Endotheliitis in COVID-19 Patients: Modulation by Veno-venous Extracorporeal Membrane Oxygenation, Arterial Hypertension and Previous Treatment with Renin-angiotensin-aldosterone System Inhibitors. 2025.